|
1.
|
A MahindraT HideshimaKC AndersonMultiple
myeloma: biology of the diseaseBlood Rev24Suppl
1S5S11201010.1016/S0268-960X(10)70003-5
|
|
2.
|
MA DimopoulosE TerposMultiple myelomaAnn
Oncol21Suppl 7S143S150201010.1093/annonc/mdq370
|
|
3.
|
S GiraltStem cell transplantation for
multiple myeloma: current and future status (Review)Hematology Am
Soc Hematol Educ
Program2011191196201110.1182/asheducation-2011.1.19122160033
|
|
4.
|
AA Chanan-KhanJ San MiguelS JagannathH
LudwigAM DimopoulosNovel therapeutic agents for the management of
multiple myeloma patients with renal impairmentClin Cancer
Res1821452163201210.1158/1078-0432.CCR-11-049822328563
|
|
5.
|
JM MarizGV EstevesReview of second-line
therapy for multiple myeloma: focus on lenalidomideCurr Opin
Oncol24Suppl
2S3S11201210.1097/01.cco.0000410243.84074.dc22245806
|
|
6.
|
M KropffHG BaylonJ HillengassThalidomide
versus dexamethasone for the treatment of relapsed and/or
refractory multiple myeloma: results from OPTIMUM, a randomized
trialHaematologica97784791201110.3324/haematol.2011.04427122133776
|
|
7.
|
A MahindraJ LaubachN RajeN MunshiPG
RichardsonK AndersonLatest advances and current challenges in the
treatment of multiple myelomaNat Rev Clin
Oncol9135143201210.1038/nrclinonc.2012.1522349016
|
|
8.
|
MJ BalunasAD KinghornDrug discovery from
medicinal plantsLife
Sci78431441200510.1016/j.lfs.2005.09.01216198377
|
|
9.
|
B OrlikovaD TasdemirF GolaisM DicatoM
DiederichDietary chalcones with chemopreventive and
chemotherapeutic potentialGenes
Nutr6125147201110.1007/s12263-011-0210-521484163
|
|
10.
|
H HaraguchiJ InoueY TamuraK
MizutaniAntioxidative components of Psoralea corylifolia
(Leguminosae)Phytother Res16539544200210.1002/ptr.972
|
|
11.
|
I JantanYH Mohd YasinS JamilH SiratN
BasarEffect of prenylated flavonoids and chalcones isolated from
Artocarpus species on platelet aggregation in human whole
bloodJ Nat Med64365369201010.1007/s11418-010-0410-020349149
|
|
12.
|
V KueteB NgameniJG TangmouoEfflux pumps
are involved in the defense of Gram-negative bacteria against the
natural products isobavachalcone and diospyroneAntimicrob Agents
Chemother5417491752201010.1128/AAC.01533-0920160051
|
|
13.
|
H JingX ZhouX DongAbrogation of Akt
signaling by Isobavachalcone contributes to its anti-proliferative
effects towards human cancer cellsCancer
Lett294167177201010.1016/j.canlet.2010.01.03520167420
|
|
14.
|
E SzliszkaZP CzubaB MazurL SedekA
ParadyszW KrolChalcones enhance TRAIL-induced apoptosis in prostate
cancer cellsInt J Mol Sci11113200910.3390/ijms1101000120161998
|
|
15.
|
O OhnoT WatabeK NakamuraInhibitory effects
of bakuchiol, bavachin, and isobavachalcone isolated from Piper
longum on melanin production in B16 mouse melanoma cellsBiosci
Biotechnol Biochem7415041506201010.1271/bbb.10022120622433
|
|
16.
|
R NishimuraK TabataM
ArakawaIsobavachalcone, a chalcone constituent of Angelica
keiskei, induces apoptosis in neuroblastomaBiol Pharm
Bull3018781883200710.1248/bpb.30.187817917255
|
|
17.
|
Y ZhaoJX PuSX Huangent-Kaurane
diterpenoids from Isodon pharicusJ Nat
Prod72988993200910.1021/np9000366
|
|
18.
|
Y HuangJK HouTT ChenPML-RARalpha enhances
constitutive autophagic activity through inhibiting the Akt/mTOR
pathwayAutophagy711321144201110.4161/auto.7.10.1663621673516
|
|
19.
|
S ShenO KeppG KroemerThe end of autophagic
cell death?Autophagy813201210.4161/auto.8.1.16618
|
|
20.
|
W HanJ SunL FengAutophagy inhibition
enhances daunorubicin-induced apoptosis in K562 cellsPLoS
One6e28491201110.1371/journal.pone.002849122164300
|
|
21.
|
VR SolomonH LeeChloroquine and its
analogs: a new promise of an old drug for effective and safe cancer
therapiesEur J
Pharmacol625220233200910.1016/j.ejphar.2009.06.06319836374
|
|
22.
|
TH ChenPC ChangMC ChangYF LinHM
LeeChloroquine induces the expression of inducible nitric oxide
synthase in C6 glioma cellsPharmacol
Res51329336200510.1016/j.phrs.2004.10.00415683746
|
|
23.
|
D DentonS NicolsonS KumarCell death by
autophagy: facts and apparent artefactsCell Death
Differ198795201210.1038/cdd.2011.14622052193
|
|
24.
|
JD ManciasAC KimmelmanTargeting autophagy
addiction in cancerOncotarget213021306201122185891
|
|
25.
|
G KroemerL GalluzziC BrennerMitochondrial
membrane permeabilization in cell deathPhysiol
Rev8799163200710.1152/physrev.00013.200617237344
|
|
26.
|
D GozuacikA KimchiAutophagy as a cell
death and tumor suppressor
mechanismOncogene2328912906200410.1038/sj.onc.120752115077152
|
|
27.
|
SF SteinbergDistinctive activation
mechanisms and functions for protein kinase CdeltaBiochem
J384449459200410.1042/BJ2004070415491280
|
|
28.
|
DN JacksonDA FosterThe enigmatic protein
kinase Cdelta: complex roles in cell proliferation and
survivalFASEB J18627636200410.1096/fj.03-0979rev15054085
|
|
29.
|
H NiM ErginSS TibudanMF DenningKF IzbanS
AlkanProtein kinase C-delta is commonly expressed in multiple
myeloma cells and its downregulation by rottlerin causes
apoptosisBr J
Haematol121849856200310.1046/j.1365-2141.2003.04368.x12786795
|
|
30.
|
D RathoreTF McCutchanM SullivanS
KumarAnti-malarial drugs: current status and new developmentsExpert
Opin Investig
Drugs14871883200510.1517/13543784.14.7.87116022576
|
|
31.
|
RG CooperT MagwereChloroquine: novel uses
& manifestationsIndian J Med Res1273053162008
|
|
32.
|
P MaycotteS AryalCT CummingsJ ThorburnMJ
MorganA ThorburnChloroquine sensitizes breast cancer cells to
chemotherapy independent of
autophagyAutophagy8200212201210.4161/auto.8.2.1855422252008
|
|
33.
|
C BellodiMR LidonniciA HamiltonTargeting
autophagy potentiates tyrosine kinase inhibitor-induced cell death
in Philadelphia chromosome-positive cells, including primary CML
stem cellsJ Clin Invest11911091123200910.1172/JCI35660
|
|
34.
|
JS CarewST NawrockiCN KahueTargeting
autophagy augments the anticancer activity of the histone
deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug
resistanceBlood110313322200710.1182/blood-2006-10-05026017363733
|
